Related Experiment Video
Updated: Jan 9, 2026
Surface-enhanced Resonance Raman Scattering Nanoprobe Ratiometry for Detecting Microscopic Ovarian Cancer via Folate Receptor Targeting
Published on: March 25, 2019
Nanozymes: An emerging perspective in tumor diagnosis and treatment since the 21st century
Qiong He1, Xuejin Hu2, Sanmao Liu3
1Nanchong City Red Cross Center Blood Station, Nanchong City, Sichuan Province, China.
Objective:
This study aims to systematically explore the development pattern and influence of nanozyme technology in the field of oncology diagnosis and treatment through bibliometric analysis methods, while identifying which countries are the innovation drivers in this field.
Methods:
On October 16, 2024, a search of the Web of Science Core Collection (WoSCC) was conducted to review and analyze the application of nanozymes in oncology. A total of 977 studies published from 2007 to 2024 were retrieved and examined.
Results:
We found that global research interest and publication volume related to this topic continue to rise. China leads in international cooperation, publication volume, and citation frequency, highlighting its outstanding position in this field. The Chinese Academy of Sciences is the largest contributing institution in terms of publication volume. Notably, ACS Applied Materials & Interfaces and Advanced Healthcare Materials are the 2 most popular journals in this field. In authors, Yang, Piaoping leads with 25 articles, and Qu, Xiaogang is the most cited author. The keyword co-occurrence network reveals 3 hotspots: "nanozymes," "photodynamic therapy," and "peroxidase-like activity"; "cell-death," "strategies," "recent progress," and "catalyst" are identified as trend topics for future exploration.
Conclusion:
Nanozymes hold significant promise for cancer diagnostics and therapy, with China, the United States, and Singapore leading the way in innovative research within this domain. Moving forward, research efforts should focus on fostering global collaboration and interdisciplinary synergy, innovate in the development of new nanozyme materials like SAzymes to improve catalytic performance and safety, investigate the potential role of nanozymes in cancer immunotherapy, and expedite the progression of nanozyme technologies from experimental settings to clinical use.
Insights
Nanozyme technology shows significant promise for cancer diagnosis and therapy. China leads global research and innovation in this rapidly advancing field, with key areas including photodynamic therapy and peroxidase-like activity.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Nanozyme technology is emerging as a powerful tool in oncology.
- Understanding the development patterns and global influence of nanozymes is crucial for advancing cancer diagnosis and treatment.
Purpose of the Study:
- To systematically analyze the development trajectory and impact of nanozyme technology in oncology.
- To identify leading countries and institutions driving innovation in nanozyme-based cancer research.
Main Methods:
- Bibliometric analysis of 977 studies published from 2007 to 2024.
- Data sourced from the Web of Science Core Collection (WoSCC).
Main Results:
- Global research interest and publication volume in nanozymes for oncology are steadily increasing.
- China leads in publication volume, international cooperation, and citation frequency.
- Key research hotspots include nanozymes, photodynamic therapy, and peroxidase-like activity, with emerging trends in cell death strategies and catalyst development.
Conclusions:
- Nanozymes offer substantial potential for cancer diagnostics and therapeutics, with China, the US, and Singapore at the forefront of research.
- Future research should prioritize global collaboration, development of novel nanozyme materials (e.g., SAzymes), exploration of nanozymes in cancer immunotherapy, and clinical translation.
More Related Videos
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
08:09Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy
Published on: April 6, 2015
